Clinical Trials Browser

Phase 1 × Skin Neoplasms × Propranolol × Clear all

NCT05968690 2025-09-18

Naltrexone and Propranolol Combined With Immunotherapy

Phase 1 Recruiting

Melanoma, Skin Neoplasms